زيمبابوي -
الإنجليزية -
Medicines Control Authority
cataflam
novartis pharma services ag - diclofenac potassium - tablet, coated; oral - 50mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
uperio
novartis pharma services ag - sacubitril; valsartan - tablet, coated; oral - 48.6; 51.4mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
co-diovan
novartis pharma services ag - hydrochlorothiazide; valsartan - tablet; oral - 12.5; 160mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
co-diovan
novartis pharma services ag - hydrochlorothiazide; valsartan - tablet; oral - 25; 160mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
exforge hct
novartis pharma services ag - amlodipine besylate; hydrochlorothiazide; valsartan - tablet; oral - 10; 12.5; 160 mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
tegretol cr 400
novartis pharma services ag - carbamazepine - tablet, coated; oral - 400mg
إسرائيل -
الإنجليزية -
Ministry of Health
lucentis
novartis israel ltd - ranibizumab - solution for injection - ranibizumab 10 mg/ml - ranibizumab - ranibizumab - treatment of patients with neovascular (wet) age-related macular degeneration (amd). treatment of adult patients with visual impairment due to diabetic macular oedema (dme) . the treatment of visual impairement due to macular oedema secondary to retinal vein occlusion (rvo). the treatment of visual impaiment due to choroidal neovascularization (cnv) . lucentis is indicated in preterm infants for: the treatment of retinopathy of prematurity (rop) with zone i (stage 1+, 2+, 3 or 3+), zone ii (stage 3+) or ap-rop (aggressive posterior rop) disease.the treatment of proliferative diabetic retinopathy (pdr)
زيمبابوي -
الإنجليزية -
Medicines Control Authority
galvus met
novartis pharma services ag - metformin hydrochloride; vildagliptin - tablet, coated; oral - 50; 1000 mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
femara
novartis pharma services ag - letrozole - tablet, coated; oral - 2.5 mg
زيمبابوي -
الإنجليزية -
Medicines Control Authority
exforge hct
novartis pharma services ag - amlodipine besylate; hydrochlorothiazide; valsartan - tablet; oral - 5; 12.5; 160mg